about
Endoluminal Vacuum Therapy for Ivor Lewis Anastomotic Leaks: A Pilot Study in a Swine Model.Complications, Not Minimally Invasive Surgical Technique, Are Associated with Increased Cost after Esophagectomy.Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivityComprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.Esophageal anastomosis - how the granulation phase of wound healing improves the incidence of anastomotic leakage.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.Is There a Rationale for Structural Quality Assurance in Esophageal Surgery?Neoadjuvant chemoradiotherapy may increase the risk of severe anastomotic complications after esophagectomy with cervical anastomosis.Evaluation of the surgical apgar score in patients undergoing Ivor-Lewis esophagectomy.Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis.Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.Enhanced recovery protocols after oesophagectomy.Fully robotic da Vinci Ivor-Lewis esophagectomy in four-arm technique-problems and solutions.Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.Prognosis Prediction for Postoperative Esophageal Cancer Patients Using Onodera's Prognostic Nutritional Index.Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.Mediastinoscopy-assisted oesophagectomy in T1 oesophageal cancer patients with serious comorbidities: a 5-year long-term follow-up.Calcification score versus arterial stenosis grading: comparison of two CT-based methods for risk assessment of anastomotic leakage after esophagectomy and gastric pull-up.
P2860
Q30275388-7F4ECDCF-D7A7-45D4-B671-91A4DAE2833BQ30832813-1B237C44-FFE1-443B-A4D0-5C27F160B579Q33828319-100E7D95-B0FD-4DEF-A85D-0A64ED6D04C6Q35763725-3F096131-D825-49B9-AF32-48B27BC2A869Q37205996-8F11EF11-F3ED-4F40-A984-16FA6FCDB2EEQ37676077-5D094780-1BBA-4946-AB8A-233CBCC5C967Q38594920-EAB2267E-6405-403F-8339-4DE96DD0E2E4Q38755193-404A9C91-05D7-47F5-ADCF-E052F13E804EQ38889292-6AD3CB39-E8F8-4CD6-976A-4204A1FEA6F0Q39039064-A26881C4-E9A5-4726-9C67-46F69C95A293Q39262598-C8AC2E1F-6A5B-425A-A92F-16C8BB3F4430Q39285940-7F2BA953-4B99-47C0-94AD-AA3597330FEBQ39582802-17A9059B-868D-4A0A-90F3-0608D66FE8B7Q41202552-7545416A-85A4-484F-BA58-60ABB7991809Q46246598-163605DE-FDBA-40E1-9139-8CEB7C041FE3Q47120642-D1536659-F2BC-484E-B909-D2F5E28E3FE6Q47770012-AC58EB3A-0350-4690-A562-479951A4EE26Q48095924-B7A0F817-2845-4478-8E96-8F7E21D8BDAAQ49726258-6F1C111D-949D-4789-AB45-6B452490E8E4Q51370517-1FEA0DB8-4256-4EEA-B3FF-5AAA049CF61FQ53655114-CA7E049A-DF18-4567-B9C2-44B1D2F16713Q55076971-2F67071A-6441-4715-AADE-43FF5C6DA28B
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Outcomes in the management of esophageal cancer.
@en
type
label
Outcomes in the management of esophageal cancer.
@en
prefLabel
Outcomes in the management of esophageal cancer.
@en
P2860
P356
P1476
Outcomes in the management of esophageal cancer.
@en
P2093
Nasser Altorki
Subroto Paul
P2860
P304
P356
10.1002/JSO.23759
P577
2014-08-21T00:00:00Z